295 related articles for article (PubMed ID: 20409415)
1. A case of CD4+/CD56+ hematodermic neoplasm (plasmacytoid dendritic cell neoplasm).
Su O; Onsun N; Demirkesen C; Aydin Y; Pirmit S; Gereli M
Dermatol Online J; 2010 Apr; 16(4):8. PubMed ID: 20409415
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature.
Li Y; Li Z; Lin HL; Chen XH; Li B
Pathol Res Pract; 2011 Jan; 207(1):55-9. PubMed ID: 20573459
[TBL] [Abstract][Full Text] [Related]
3. CD4+/CD56+ Hematodermic neoplasm (plasmacytoid dendritic cell tumor).
Shiman M; Marchione R; Ricotti C; Romanelli P; Alonso-Llamazares J
Dermatol Online J; 2008 Nov; 14(11):5. PubMed ID: 19094843
[TBL] [Abstract][Full Text] [Related]
4. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
[TBL] [Abstract][Full Text] [Related]
5. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
[TBL] [Abstract][Full Text] [Related]
6. Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.
Ruggiero A; Maurizi P; Larocca LM; Arlotta A; Riccardi R
Haematologica; 2006 Dec; 91(12 Suppl):ECR48. PubMed ID: 17194654
[TBL] [Abstract][Full Text] [Related]
7. CD4+/CD56+ haematodermic neoplasm: a preculsor haematological neoplasm that frequently first presents in the skin.
Martín JM; Nicolau MJ; Galán A; Ferrández-Izquierdo A; Ferrer AM; Jordá E
J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1129-32. PubMed ID: 16987271
[TBL] [Abstract][Full Text] [Related]
8. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
Patel JL; Shetty S; Salama ME
Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
[TBL] [Abstract][Full Text] [Related]
9. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
[TBL] [Abstract][Full Text] [Related]
10. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
Herling M; Jones D
Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
[TBL] [Abstract][Full Text] [Related]
11. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
Leitenberger JJ; Berthelot CN; Polder KD; Pro B; McLaughlin P; Jones D; Duvic M
J Am Acad Dermatol; 2008 Mar; 58(3):480-4. PubMed ID: 18280345
[TBL] [Abstract][Full Text] [Related]
12. [Sustained remission of blastic plasmacytoid dendritic cell neoplasm with ABVD chemotherapy].
Tanikawa S; Sakuranaka H; Chong JM; Okada Y; Takimoto M
Rinsho Ketsueki; 2012 Feb; 53(2):246-51. PubMed ID: 22450587
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous CD4+/CD56+ hematodermic neoplasm.
Zindanci I; Kavala M; Buyukbabani N; Kocaturk E; Koc M
Indian J Dermatol Venereol Leprol; 2010; 76(6):723. PubMed ID: 21079332
[TBL] [Abstract][Full Text] [Related]
14. CD2- CD4+ CD56+ hematodermic/hematolymphoid malignancy.
Kato N; Yasukawa K; Kimura K; Sugawara H; Aoyagi S; Mishina T; Nakata T
J Am Acad Dermatol; 2001 Feb; 44(2):231-8. PubMed ID: 11174380
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases.
Ng AP; Lade S; Rutherford T; McCormack C; Prince HM; Westerman DA
Haematologica; 2006 Jan; 91(1):143-4. PubMed ID: 16434387
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
[TBL] [Abstract][Full Text] [Related]
17. CD4+ CD56+ hematodermic neoplasm and plasmacytoid dendritic cell tumor: case report and review of the literature.
Campbell SM; Moad JC; Sammons DL; Zirwas M
Cutis; 2012 Jun; 89(6):278-83. PubMed ID: 22838092
[TBL] [Abstract][Full Text] [Related]
18. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
[TBL] [Abstract][Full Text] [Related]
19. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
Mitteldorf C; Bertsch HP; Baumgart M; Haase D; Wulf G; Schön MP; Rosenwald A; Neumann C; Kaune KM
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1225-9. PubMed ID: 21923812
[TBL] [Abstract][Full Text] [Related]
20. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
